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To the Editor,
Epidermolysis bullosa (EB) with pyloric atresia (PA) is an au-
tosomal recessive form of EB subtype that affects the skin, as 
well as digestive and frequently urogenital tracts. EB-PA is clas-
sified as the simplex form caused by the plectin gene (PLEC) 
mutations and the junctional form caused by integrin α6β4 
genes (ITGA6, ITGB4) mutations.1-5 However, the intracellular 
domain of integrin β4 interacts with other hemidesmosomal 
components of basal keratinocytes, including plectin.6 A recent 
review on the transmission electron microscopy (TEM) findings 
of EB-PA patients who showed absent expression of integrin β4 
reported a consistent level of cleavage planes through concur-
rent low intra-basal epidermal and lamina lucida,7 suggesting 
that the loss of integrin β4 can lead to this unique ultrastructural 
finding.
We previously reported a Korean male newborn who pre-
sented with PA with mucocutaneous blisters at birth.8 Wide-
spread blisters were found on the entire body and oral mucosa, 
and they eventually healed without significant scarring. Nail 
dystrophy was observed on the right thumb. Multiple urologic 
abnormalities including bilateral hydronephrosis, hydroureter, 
and a distended trabeculated bladder were noted at 12 months 
of age. Immunofluorescence mapping and TEM performed at 
infancy revealed the localization of type IV and VII collagen to 
the blister base and intra-basal epidermal cleavages with tono-
filaments clumping, respectively, leading to a diagnosis of EB 
simplex, generalized severe, formerly called Dowling-Meara 
type with PA and urologic abnormalities.8 The patient’s father, 
paternal brother, and sister had reported bullae without any 
anomalies, which had spontaneously improved. In this report, 
we describe compound heterozygous mutations in integrin β4 
in this patient, which were not previously identified. Next-gen-
eration sequencing performed after obtaining informed con-
sent revealed compound heterozygous missense mutations, 
c.113G>T (p.C38F) in exon 3 and c1274A>C (p.Q425P) in exon 
11 of ITGB4 gene, which were confirmed by additional Sanger 
sequencing (Fig. 1A). Mutations in PLEC or keratin genes have 
not been detected. Missense mutation of p.Q425P has been re-
ported in EB-PA.9-11 p.C38F in ITGB4 was reported as a codon 
variant, but has not been reported to be associated with EB.12 
Two in silico tools, including SIFT and PolyPhen-2, predicted 
that this amino acid substitution in ITGB4 is likely pathogenic. 
Cutaneous symptoms improved with age, showing only blister-
ing limited to the extremities and inguinal area at age 22 (Fig. 1B). 
Integrin β4 consists of an intracytoplasmic domain connect-
ed to keratin intermediate filaments via binding to plectin and 
type XVII collagen and an extracellular domain connected to 
laminin. ITGB4 mutations are the most frequent cause of EB-
PA, and EB-PA caused by ITGB4 mutations has been classified 
as a form of junctional EB,4 but a previous paper reported that 
the deletion of a cytoplasmic domain of integrin β4 causes EB 
simplex without PA.13 This indicated that mutations in the intra-
cytoplasmic domain of integrin β4 may result in intrabasal splits, 
suggesting EB simplex rather than junctional EB.13 In this case, 
despite the compound heterozygous missense mutations in the 
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extracellular domain of integrin β4, TEM showed cleavages 
above the hemidesmosome and keratin clumping in the basal 
keratinocytes, resembling the finding in EB simplex, general-
ized severe. Besides, the expression of plectin was reduced in 
the patient’s skin, despite the absence of mutations in PLEC (Fig. 
1C). These findings might be possibly due to the impaired stabi-
lization of plectin by integrin β4, which in turn, may affect the 
interaction with keratin intermediate filaments. However, to ex-
clude the possibility of artificial cleavages within the basal cells 
or dermo-epidermal junction and to confirm the type of EB-PA, 
thorough inspection of numerous sections of TEM samples will 
be further required. Based on the position of ITGB4 mutations, 
our case is thought to be junctional EB-PA.
The prognosis of junctional EB-PA is generally poor, but spon-
taneous amelioration of symptoms with aging has been report-
ed in rare cases.14,15 Our case is also considered to belong to this 
rare subgroup.
Among the ITGB4 missense mutations in our case, we found 
p.C38F in ITGB4. Another mutation at the same codon 38 
(p.C38R) has been reported in EB-PA patients,16 but p.C38F has 
not been reported to be associated with EB-PA. Another inter-
esting finding in our case was that the patient presented with 
mild skin lesions possibly due to compound heterozygous mis-
sense mutations in ITGB4, but relatively severe and multiple 
congenital urologic abnormalities, suggesting that genotype-
phenotype correlations are not always evident in EB-PA with 
ITGB4 mutations. Collectively, our case expands the genotypic 
and phenotypic spectrum and ultrastructural findings of EB-PA 
caused by ITGB4 mutations.
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